News
A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...
10h
Zacks Investment Research on MSNBayer Gets CHMP Nod for Eylea 8 mg in the EU for 2 Major Eye DiseasesBayer BAYRY announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...
12h
Pharmaceutical Technology on MSNBayer’s Eylea set for longer treatment intervals to challenge Roche’s VabysmoAn EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results